Published in Eur J Endocrinol on April 29, 2016
A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmacokinet Biopharm (1987) 8.01
The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA (1992) 6.96
Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc Natl Acad Sci U S A (2009) 6.67
Adrenal insufficiency. Lancet (2003) 5.34
Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet (2001) 4.14
Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. J Clin Endocrinol Metab (2001) 2.97
Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects. J Clin Endocrinol Metab (1971) 2.48
Diurnal cortisol decline is related to coronary calcification: CARDIA study. Psychosom Med (2006) 2.17
Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation. J Clin Endocrinol Metab (2011) 2.16
Metabolic effects of short-term elevations of plasma cortisol are more pronounced in the evening than in the morning. J Clin Endocrinol Metab (1999) 2.06
Premature mortality in patients with Addison's disease: a population-based study. J Clin Endocrinol Metab (2006) 1.75
Self-reported sleep duration and sleep disturbance are independently associated with cortisol secretion in the Whitehall II study. J Clin Endocrinol Metab (2009) 1.63
Modified-release hydrocortisone to provide circadian cortisol profiles. J Clin Endocrinol Metab (2009) 1.57
Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency. Clin Endocrinol (Oxf) (2008) 1.41
Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency. Clin Endocrinol (Oxf) (2004) 1.22
Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy. Eur J Endocrinol (2009) 1.14
High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study. J Clin Endocrinol Metab (2014) 1.14
Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study. Eur J Endocrinol (2009) 1.12
The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients. J Clin Endocrinol Metab (2006) 1.11
A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome. Clin Endocrinol (Oxf) (1995) 1.06
Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency. Clin Endocrinol (Oxf) (2010) 0.98
Adrenal insufficiency: review of clinical outcomes with current glucocorticoid replacement therapy. Clin Endocrinol (Oxf) (2014) 0.96
Pharmacokinetic evidence for suboptimal treatment of adrenal insufficiency with currently available hydrocortisone tablets. Clin Pharmacokinet (2010) 0.95
Impact of reducing dosing frequency on adherence to oral therapies: a literature review and meta-analysis. Patient Prefer Adherence (2013) 0.95
Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality. J Clin Endocrinol Metab (2013) 0.91
Replication of cortisol circadian rhythm: new advances in hydrocortisone replacement therapy. Ther Adv Endocrinol Metab (2010) 0.90
Effect of dose size on the pharmacokinetics of oral hydrocortisone suspension. J Pharm Sci (1982) 0.89
Determination of cortisol in serum, saliva and urine. Best Pract Res Clin Endocrinol Metab (2013) 0.85
Episodic ACTH and cortisol secretion in normal children. Clin Endocrinol (Oxf) (1991) 0.83
Correction of cortisol overreplacement ameliorates morbidities in patients with hypopituitarism: a pilot study. Pituitary (2008) 0.83
Modified-release hydrocortisone decreases BMI and HbA1c in patients with primary and secondary adrenal insufficiency. Eur J Endocrinol (2015) 0.83
Improving outcomes in patients with adrenal insufficiency: a review of current and future treatments. Curr Med Res Opin (2014) 0.82
Incidence of adrenal crisis in patients with adrenal insufficiency. Clin Endocrinol (Oxf) (2015) 0.82
Neuropeptides and human sleep. Sleep (1997) 0.81
Oral hydrocortisone pharmacokinetics: a comparison of fluorescence and ultraviolet high-pressure liquid chromatographic assays for hydrocortisone in plasma. J Pharm Sci (1982) 0.80
Guidelines for the diagnosis and treatment of adrenal insufficiency in the adult. Endocrinol Nutr (2014) 0.78
Sleep and wakefulness affect the responsiveness of the pituitary-adrenocortical axis to arginine vasopressin in humans. Neuroendocrinology (1994) 0.77
The dexamethasone suppression test in healthy controls. Psychoneuroendocrinology (1987) 0.77
Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency: a phase 3b, open-label, extension study. Eur J Endocrinol (2017) 0.75
Prednisolone is associated with a worse lipid profile than hydrocortisone in patients with adrenal insufficiency. Endocr Connect (2016) 0.75